Novel Approaches To Tackling Obesity, Cancer And MRSA
Obesity, cancer and the hospital 'superbug' MRSA are the targets for novel drugs being developed under a new scheme funded by the Wellcome Trust. The Seeding Drug Discovery initiative aims to bridge the funding gap for health researchers involved in early-stage drug discovery projects that will be the springboard for further research and development by the biotech and pharmaceutical industry.
Speakers:
* Seeding Drug Discovery - Dr Ted Bianco (Technology Transfer Division, Wellcome Trust)
* Natural gut hormone offers hope for new obesity drug - Professor Steve Bloom (Imperial College London)
* New antibacterials being developed to tackle MRSA -Dr Lloyd Czaplewski (Prolysis)
* Novel approach to cancer drug - Professor Jeremy TavarĐ“© (University of Bristol)
###
Contact: Craig Brierley
Wellcome Trust
No comments:
Post a Comment